Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Chimerix (CMRX) News Today

$0.99
+0.02 (+1.83%)
(As of 05/17/2024 08:53 PM ET)
Chimerix (NASDAQ:CMRX) Lifted to Hold at StockNews.com
Chimerix (NASDAQ:CMRX) Downgraded by StockNews.com to "Sell"
StockNews.com cut Chimerix from a "hold" rating to a "sell" rating in a report on Friday.
Brokers Offer Predictions for Chimerix, Inc.'s FY2028 Earnings (NASDAQ:CMRX)
Chimerix, Inc. (NASDAQ:CMRX - Free Report) - Equities research analysts at Capital One Financial reduced their FY2028 earnings per share estimates for shares of Chimerix in a research report issued on Wednesday, May 1st. Capital One Financial analyst N. Quibria now anticipates that the biopharmac
Chimerix (NASDAQ:CMRX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS
Chimerix (NASDAQ:CMRX - Get Free Report) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.04). Chimerix had a negative net margin of 25,337.96% and a negative return on equity of 37.93%. During the same quarter in the previous year, the firm posted ($0.24) EPS.
Q1 2024 Chimerix Inc Earnings Call
Chimerix GAAP EPS of -$0.25
Chimerix: Q1 Earnings Snapshot
What Wall Street expects from Chimerix's earnings
Chimerix (CMRX) Set to Announce Quarterly Earnings on Wednesday
Chimerix (NASDAQ:CMRX) will be releasing earnings before the market opens on Wednesday, May 1, Zacks reports.
CMRX Apr 2024 1.000 put
CMRX Apr 2024 2.000 call
Chimerix (NASDAQ:CMRX) Earns "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $11.00 price target on shares of Chimerix in a report on Friday.
Preview: Chimerix's Earnings
Chimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99
Chimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99
Chimerix Appoints Lisa Decker to Board of Directors
Positive Signs As Multiple Insiders Buy Chimerix Stock
Chimerix Appoints Michelle LaSpaluto As CFO
Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.

Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

CMRX Media Mentions By Week

CMRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMRX
News Sentiment

0.00

0.42

Average
Medical
News Sentiment

CMRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMRX Articles
This Week

2

1

CMRX Articles
Average Week

Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CMRX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners